Panobinostat acts synergistically with ibrutinib in diffuse large B cell lymphoma cells with MyD88 L265P mutations
Patrizia Mondello(Memorial Sloan Kettering Cancer Center), Anas Younes(Memorial Sloan Kettering Cancer Center)
Cited by 46
Related Papers
Induction of Cell Cycle Arrest and Apoptosis by the Proteasome Inhibitor PS-341 in Hodgkin Disease Cell Lines Is Independent of Inhibitor of Nuclear Factor-κB Mutations or Activation of the CD30, CD40, and RANK Receptors
|Clinical Cancer Research|2004|109
The antileukemia activity of a human anti-CD40 antagonist antibody, HCD122, on human chronic lymphocytic leukemia cells
|Blood|2008|103
The JAK inhibitor AZD1480 regulates proliferation and immunity in Hodgkin lymphoma
|Blood Cancer Journal|2011|70